Europe — EMA
Palonosetron Kalceks
Palonosetron, the active ingredient in Palonosetron Kalceks, is a 5-HT3 receptor antagonist presented as a strength/form for intravenous use.
Request sourcing
What is Palonosetron?
Palonosetron, the active ingredient in Palonosetron Kalceks, is a 5-HT3 receptor antagonist presented as a strength/form for intravenous use. It treats and prevents nausea and vomiting associated with chemotherapy and surgery in adult patients. GNH USA supplies Palonosetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.
GNH USA supplies Palonosetron Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.
What is Palonosetron used for?
Palonosetron Kalceks is a selective 5‑HT3 receptor antagonist used in the management of nausea and vomiting pathways.
- Chemotherapy‑induced nausea and vomiting (CINV): Helps prevent the acute and delayed phases of CINV. - Post‑operative nausea and vomiting (PONV): Reduces the incidence of nausea and vomiting after surgery. - Radiotherapy‑induced nausea and vomiting: Provides prophylaxis against nausea and vomiting associated with radiation therapy. - Anticipatory anticonvuls Ant ".
